• U.S. hemp farmers are leaving Canada in the dust

    Published On: October 9, 2019

    Struggling American family farms are praising a cash crop worth more than US$45,000 per acre. According to projections by market research firm Brightfield Group, the hemp-derived CBD boom isn’t cropping up nearly as much [...]

  • Making CBD health claims? Careful Before Disseminating

    Published On: September 10, 2019

    Companies and consumers are talking in a different way these days about cannabidiol (CBD), a chemical compound derived from the cannabis plant. But even as the conversation changes, one thing remains the same. Before [...]

  • FTC Sends Warning Letters to Companies Advertising Their CBD-Infused Products as Treatments for Serious Diseases, Including Cancer, Alzheimer’s, and Multiple Sclerosis

    Published On: September 10, 2019

    As part of its regular monitoring of health-related advertising claims, the Federal Trade Commission today sent warning letters to three companies that sell oils, tinctures, capsules, “gummies,” and creams containing cannabidiol (CBD), a chemical [...]

  • FDA is Committed to Sound, Science-based Policy on CBD

    Published On: July 17, 2019

    Science forms the basis for decisions at the U.S. Food and Drug Administration (FDA) and is paramount when it comes to making decisions that will impact the health and safety of the American public. [...]

  • FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety

    Published On: July 2, 2019

    Today, the U.S. Food and Drug Administration announced that it has issued a warning letter to Curaleaf Inc., of Wakefield, Massachusetts, for illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that [...]